Emon Heidari
Associate
Dr. Emon Heidari is an associate in the San Diego office of Wilson Sonsini Goodrich & Rosati, where he is a member of the firm’s patents and innovations practice. Prior to joining the firm, Emon was a George Hewitt postdoctoral fellow in the laboratory of Brian J.F. Wong at The Beckman Laser Institute. His research areas included investigating the in-situ and in-vivo electrochemical effect of adipose lipolysis. His doctoral work focused on developing high- resolution non-invasive optical imaging systems and probes to track changes in anatomy and physiology of developing disease states.
Experience
Dr. Emon Heidari is an associate in the San Diego office of Wilson Sonsini Goodrich & Rosati, where he is a member of the firm’s patents and innovations practice. Prior to joining the firm, Emon was a George Hewitt postdoctoral fellow in the laboratory of Brian J.F. Wong at The Beckman Laser Institute. His research areas included investigating the in-situ and in-vivo electrochemical effect of adipose lipolysis. His doctoral work focused on developing high- resolution non-invasive optical imaging systems and probes to track changes in anatomy and physiology of developing disease states.
Education
- J.D., University of San Diego School of Law, 2025Concentration in Intellectual Property Law
- Ph.D., Biomedical Engineering, University of California, Irvine, 2018
- B.S., Biomedical Engineering, University of California, Irvine, 2010
Admissions
- State Bar of California
- U.S. Patent and Trademark Office
Credentials
Education
- J.D., University of San Diego School of Law, 2025Concentration in Intellectual Property Law
- Ph.D., Biomedical Engineering, University of California, Irvine, 2018
- B.S., Biomedical Engineering, University of California, Irvine, 2010
Admissions
- State Bar of California
- U.S. Patent and Trademark Office
Select Publications
- Co-author with T.T. Pham, I. Ifegwu, R. Burwell, W.B. Armstrong, T. Tjoa, S. Whyte, C. Giorgioni, B. Wang, B.F.G. Wong, and Z. Chen, “The Use of Optical Coherence Tomography and Convolutional Neural Networks to Distinguish Normal and Abnormal Oral Mucosa,” 13(3) Journal of Biophotonics, 2020
- Co-author with S.P. Sunny, B.L. James, et al., “Optical Coherence Tomography as an Oral Cancer Screening Adjunct in a Low Resource Settings,” 25(1):1-8 Institute of Electrical and Electronic Engineers, 2019
- Co-author with S. Moghaddam, K.K. Truong, L. Chou, C. Genberg, M. Brenner, and Z. Chen, “Visualizing Biofilm Formation in Endotracheal Tubes Using Endoscopic Three-Dimensional Optical Coherence Tomography,” 20(12) Journal of Biomedical Optics, 2015
- Co-author with S.W. Lee, D. Yoon, D. Mukai, R. Tirunelveli, S. Mahon, J. Yin, G. Liu, Z. Chen, and M. Brenner, “Quantification of Airway Thickness Changes in Smoke-Inhalation Injury Using In-Vivo 3-D Endoscopic Frequency-Domain Optical Coherence Tomography,” 2(2) Biomedical Optics Express, 2011
- Co-author with T.T. Pham, A.A. Hakimi, Y. Li, C. Heilbronn, E. Hong, J.H. Mo, Z. Chen, and B.F.G. Wong, “Optical Coherence Tomography Visualization of Olfactory Mucosa and Cribriform Fo-ramina in an Ex Vivo Rabbit Model,” Submitted to American Journal of Rhinology & Allergy, 2019
Insights
Select Publications
- Co-author with T.T. Pham, I. Ifegwu, R. Burwell, W.B. Armstrong, T. Tjoa, S. Whyte, C. Giorgioni, B. Wang, B.F.G. Wong, and Z. Chen, “The Use of Optical Coherence Tomography and Convolutional Neural Networks to Distinguish Normal and Abnormal Oral Mucosa,” 13(3) Journal of Biophotonics, 2020
- Co-author with S.P. Sunny, B.L. James, et al., “Optical Coherence Tomography as an Oral Cancer Screening Adjunct in a Low Resource Settings,” 25(1):1-8 Institute of Electrical and Electronic Engineers, 2019
- Co-author with S. Moghaddam, K.K. Truong, L. Chou, C. Genberg, M. Brenner, and Z. Chen, “Visualizing Biofilm Formation in Endotracheal Tubes Using Endoscopic Three-Dimensional Optical Coherence Tomography,” 20(12) Journal of Biomedical Optics, 2015
- Co-author with S.W. Lee, D. Yoon, D. Mukai, R. Tirunelveli, S. Mahon, J. Yin, G. Liu, Z. Chen, and M. Brenner, “Quantification of Airway Thickness Changes in Smoke-Inhalation Injury Using In-Vivo 3-D Endoscopic Frequency-Domain Optical Coherence Tomography,” 2(2) Biomedical Optics Express, 2011
- Co-author with T.T. Pham, A.A. Hakimi, Y. Li, C. Heilbronn, E. Hong, J.H. Mo, Z. Chen, and B.F.G. Wong, “Optical Coherence Tomography Visualization of Olfactory Mucosa and Cribriform Fo-ramina in an Ex Vivo Rabbit Model,” Submitted to American Journal of Rhinology & Allergy, 2019
Diagnostics and Medical Devices
- Biomedical devices
- Biomedical engineering
- Biosensors
- Diagnostics
- Digital pathology
- Medical devices
- Medical imaging
- Neuroimaging
- Point-of-care testing (POCT)
- Telemedicine technology
- Wearable analyte sensors
Engineering and Technology
- 3D bioprinting
- AI
- Biomechanics
- Machine learning
- Microfluidics
- Nanorobotics
- Robotics
Genomics and Data Analysis
- Next-generation sequencing
- Sequencing
Miscellaneous
- Cancer
- Design patent
- Fluorescence microscopy
- Ophthalmology
- Physics
Technical Fluency
Diagnostics and Medical Devices
- Biomedical devices
- Biomedical engineering
- Biosensors
- Diagnostics
- Digital pathology
- Medical devices
- Medical imaging
- Neuroimaging
- Point-of-care testing (POCT)
- Telemedicine technology
- Wearable analyte sensors
Engineering and Technology
- 3D bioprinting
- AI
- Biomechanics
- Machine learning
- Microfluidics
- Nanorobotics
- Robotics
Genomics and Data Analysis
- Next-generation sequencing
- Sequencing
Miscellaneous
- Cancer
- Design patent
- Fluorescence microscopy
- Ophthalmology
- Physics
Recent Insights
Client Highlights
Wilson Sonsini Advises Apton on Patent Matters in Acquisition
On August 2, 2023, Pacific Biosciences of California (PacBio), a leading provider of high-quality, long-read sequencing platforms, announced that it has signed a definitive merger agreement to acquire Apton Biosystems, Inc. (Apton), a Bay-Area-based company developing a high throughput short-read sequencer using state-of-the-art optics and image processing, paired with novel clustering and chemistry, that is designed to enable the sequencing of billions of clusters of DNA on one flow cell. Wilson Sonsini Goodrich & Rosati is representing PacBio in the transaction. Wilson Sonsini advised Apton Biosciences on patent matters related to the transaction.
Learn More
- Privacy Policy
- Terms of Use
- Accessibility
Copyright © 2026 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.